IMGN

ImmunoGen, Inc. Press Releases

$13.99
*  
0.22
 negative 
1.55%
Get IMGN Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

ImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2014 Financial Results
4/17/2014 4:20:00 PM - Business Wire

Pre-Market Scans on Top Gainers -- Research on Athlon Energy, Venaxis, Desarrolladora Homex, and ImmunoGen
4/10/2014 1:30:00 PM - PR Newswire

ImmunoGen, Inc. Announces First Clinical Findings with Refined Dosing Strategy for IMGN853
4/8/2014 4:15:00 PM - Business Wire

Earnings Release and Presentation Schedules, Nominations, and Financial Results - Analyst Notes on Five Prime Therapeutics, Acceleron, Emergent BioSolutions, CONMED, and ImmunoGen
3/21/2014 8:00:00 AM - PR Newswire

ImmunoGen, Inc. Announces Presentations by Company Scientists at Upcoming AACR Annual Meeting
3/17/2014 11:30:00 AM - Business Wire

IDEXX Laboratories Elects Daniel Junius to Board of Directors
3/11/2014 4:15:00 PM - PR Newswire

ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
2/27/2014 4:39:00 PM - Business Wire

ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences
2/6/2014 3:00:00 PM - Business Wire

ImmunoGen, Inc. Appoints Eric Guempel as Vice President of Product Strategy and Program Management
1/31/2014 6:35:00 AM - Business Wire

ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2014 Financial Results and Provides Corporate Update
1/31/2014 6:30:00 AM - Business Wire

ImmunoGen, Inc. Announces Conference Call to Discuss its Second Quarter Fiscal Year 2014 Financial Results
1/24/2014 6:30:00 AM - Business Wire